Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

OSIR

Osiris Therapeutics, Inc. (OSIR)

Osiris Therape (MM)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:OSIR

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
29/04/2019	22h13	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h48	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h19	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h18	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h18	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h18	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h18	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h15	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	15h05	GlobeNewswire Inc.	Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plc	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	12h08	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:OSIR	Osiris Therape (MM)
17/04/2019	12h08	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:OSIR	Osiris Therape (MM)
16/04/2019	15h02	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:OSIR	Osiris Therape (MM)
12/04/2019	14h57	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:OSIR	Osiris Therape (MM)
10/04/2019	15h34	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:OSIR	Osiris Therape (MM)
10/04/2019	15h30	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:OSIR	Osiris Therape (MM)
27/03/2019	22h20	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:OSIR	Osiris Therape (MM)
27/03/2019	22h13	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:OSIR	Osiris Therape (MM)
20/03/2019	12h43	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:OSIR	Osiris Therape (MM)
20/03/2019	12h33	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:OSIR	Osiris Therape (MM)
15/03/2019	23h13	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Osiris Therapeutics, Inc.	NASDAQ:OSIR	Osiris Therape (MM)
15/03/2019	14h03	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:OSIR	Osiris Therape (MM)
12/03/2019	22h10	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:OSIR	Osiris Therape (MM)
12/03/2019	22h07	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:OSIR	Osiris Therape (MM)
12/03/2019	22h03	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:OSIR	Osiris Therape (MM)
12/03/2019	18h14	PR Newswire (US)	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc.	NASDAQ:OSIR	Osiris Therape (MM)
12/03/2019	14h33	PR Newswire (US)	Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.	NASDAQ:OSIR	Osiris Therape (MM)
12/03/2019	14h22	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:OSIR	Osiris Therape (MM)

Showing the most relevant articles for your search:NASDAQ:OSIR

1 2 3 4 5 6 7 8 9 10 Next >>

Energy Select Sector SPDR

JP Morgan Chase

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen